← Leaderboards
Haifeng Eishingdrelo
Bioinvenu Corporation
$2,789,580
Attributed
$2,789,580
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $773.2K · FY2013–23$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$2,789,580 · 5
By mechanism
R44$1,540,013 · 1
R43$1,249,567 · 4
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Technology”
- David Heimbrook · Leidos Biomedical Research, Inc.$995,338,451
- Sonia M Thomas · Research Triangle Institute$700,865,642
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Eric S Lander · Whitehead Institute For Biomedical Res$606,570,095
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Richard K. Wilson · Washington University$441,856,657
Research focus
TechnologyReceptorSignal PathwayLigandsLinkSignal TransductionGtp-Binding ProteinsAgonistMediatingResponseAssay DevelopmentComplexPhysiologicalProteinsDrug DiscoveryPathway InteractionsG Protein-Coupled Receptor SignalingG-Protein-Coupled ReceptorsBeta-ArrestinBrainMental HealthBasePharmaceutical PreparationsCollaborations
Grant awards (6)
New 5HT2AR Target Identification and Assay Development for Discovering Psychoplastogenic Compounds$319,343
R43 · FY2023 · DA · contact PI
Screen molecules modulating MOR trafficking with a newly developed MOR/14-3-3 bioassay.$321,000
R43 · FY2019 · DA · contact PI
Novel tools for investigating GPCR-mediated 14-3-3 signaling pathway$766,778
R44 · FY2018 · MH · contact PI
Novel tools for investigating GPCR-mediated 14-3-3 signaling pathway$773,235
R44 · FY2017 · MH · contact PI
Novel tools for investigating GPCR-mediated 14-3-3 signaling pathway$330,536
R43 · FY2016 · MH · contact PI
Novel tools for identifying GPCR compounds modulating specific sub-cellular ERK a$278,688
R43 · FY2013 · MH · contact PI